Pd-169316

Pd-169316

SCHEMBL154958

O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 17/20 1.00
MAPK11 Q15759 16/20 1.00
MAPK13 O15264 15/20 1.00
MAPK12 P53778 15/20 1.00
ALOX5 P09917 12/20 1.00
ALDH1A1 P00352 4/20 1.00
RIPK2 O43353 3/20 1.00
CYP3A4 P08684 3/20 1.00
ALOX15 P16050 3/20 1.00
MAPK1 P28482 3/20 1.00
GMNN O75496 2/20 1.00
LMNA P02545 2/20 1.00
MAPT P10636 2/20 1.00
NFKB1 P19838 2/20 1.00
THPO P40225 2/20 1.00
BLM P54132 2/20 1.00
PMP22 Q01453 2/20 1.00
TDP1 Q9NUW8 2/20 1.00
MEN1 O00255 2/20 1.00
KMT2A Q03164 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pd-169316 SCHEMBL9899161 1.00 MAPK14 (1.00) MAPK14MAPK11MAPK13MAPK12ALOX5
SCHEMBL13741880 0.89 MAPK11 (0.80) MAPK14MAPK11MAPK13MAPK12ALOX5
SCHEMBL6449323 0.87 MAPK14 (0.77) MAPK14MAPK11MAPK13MAPK12ALOX5
SCHEMBL2125126 0.87 MAPT (0.75) MAPK14MAPK11MAPK13MAPK12ALOX5
SCHEMBL19868925 0.87 MAPK11 (1.00) MAPK14MAPK11MAPK13MAPK12ALOX5
SCHEMBL15075603 0.87 MAPK11 (1.00) MAPK14MAPK11MAPK13MAPK12ALOX5
SCHEMBL31029949 0.82 MAPK14 (0.70) MAPK14MAPK11MAPK13MAPK12ALOX5
SCHEMBL17002220 0.82 MAPK14 (0.69) MAPK14MAPK11MAPK13MAPK12ALOX5
SCHEMBL6469468 0.82 MAPK11 (0.69) MAPK14MAPK11MAPK13MAPK12ALOX5
SCHEMBL4552316 0.81 MAPK14 (1.00) MAPK14MAPK11MAPK13MAPK12ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 564 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720261-A1 NOVEL CULTURE CONDITIONS FOR CLONAL EXPANSION OF NEPHRON PROGENITOR CELLS, GENERATION OF NEPHRON ORGANOIDS, AND RAPID AND SCALABLE MODELING OF POLYCYSTIC KIDNEY DISEASE University of Southern California (US) 2026-04-08 EP claimed
US-12503685-B2 Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2025-12-23 US claimed
WO-2025069029-A1 METHODS FOR REJUVENATING HUMAN CELLS CENTARIX BIOTECH LTD (IL) 2025-04-03 WO claimed
CN-119372130-A Culture medium for stem cells 荷兰皇家科学院 2025-01-28 CN claimed
WO-2024243567-A1 NOVEL CULTURE CONDITIONS FOR CLONAL EXPANSION OF NEPHRON PROGENITOR CELLS, GENERATION OF NEPHRON ORGANOIDS, AND RAPID AND SCALABLE MODELING OF POLYCYSTIC KIDNEY DISEASE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2024-11-28 WO claimed
US-20240318144-A1 MEDIA FOR CULTURING NAIVE HUMAN PLURIPOTENT STEM CELLS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2024-09-26 US claimed
WO-2024189434-A1 USE OF NADOLOL TO TREAT PULMONARY SYMPTOMS ASSOCIATED WITH INFECTIONS WITH SARS-CoV-2 CHRONIC AIRWAY THERAPEUTICS LIMITED (AU) 2024-09-19 WO claimed
CN-109415699-B Preparation method of CD4CD8 double-positive T cells 国立大学法人京都大学 2024-08-27 CN claimed
CN-118105493-A Skeletal muscle generation inducer, pharmaceutical composition, kit and application thereof 北京大学 2024-05-31 CN claimed
EP-4324913-A2 CULTURE MEDIA FOR STEM CELLS Koninklijke Nederlandse Akademie van Wetenschappen (KNAW) (NL) 2024-02-21 EP claimed
US-6465493-B1 SUCH AS 4-(4-(4-FLUOROPHENYL)-5-(2-PYRIDYL)-1-HYDROXY-1H-IMIDAZOL-2-YL)BENZONITRILE; ALK5 MEDIATED DISEASES SUCH AS ARTHRITIS, OSTEOPOROSIS, KIDNEY AND RENAL DISEASES, CONGES-TIVE HEART FAILURE, ULCERS, DIABETIC NEPHROPATHY SMITHKLINE BEECHAM CORPORATION 2002-10-15 US claimed
EP-0959885-A4 TRIARYL SUBSTITUTED IMIDAZOLES AND METHODS OF USE MERCK & CO INC (US) 2002-07-17 EP claimed
US-20020028798-A1 Irrigation solution and method for inhibition of pain and inflammation OMEROS MEDICAL SYSTEMS 2002-03-07 US claimed
EP-1169317-A1 TRIARYLIMIDAZOLES SMITHKLINE BEECHAM CORPORATION (US) 2002-01-09 EP claimed
US-6288089-B1 ADMINISTERING A COMPOSITION OF PYRIDYL IMIDAZOLE COMPOUNDS TO TREAT PARKINSON'S DISEASE, HUNTINGTON'S DISEASE, ALZHEIMER'S DISEASE, AND AMYOTOPHIC LATERAL SCLEROSIS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2001-09-11 US claimed
WO-2000061576-A1 TRIARYLIMIDAZOLES SMITHKLINE BEECHAM CORPORATION (US) 2000-10-19 WO claimed
WO-2000023072-A1 IRRIGATION SOLUTION CONTAINING MAPK INHIBITORS AND THEIR USE FOR TREATING PAIN AND INFLAMMATION OMEROS MEDICAL SYSTEMS, INC. (US) 2000-04-27 WO claimed
EP-0959885-A1 TRIARYL SUBSTITUTED IMIDAZOLES AND METHODS OF USE Merck & Co., Inc. (US) 1999-12-01 EP claimed
WO-1998022108-A1 TRIARYL SUBSTITUTED IMIDAZOLES AND METHODS OF USE MERCK & CO., INC. (US) 1998-05-28 WO claimed
US-5656644-A CYTOKINE SUPPRESSORS SMITHKLINE BEECHAM CORPORATION (US) 1997-08-12 US claimed